CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins-Reference-Cited by-同舟云学术

CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins

Published:2020-01-01 Issue:1 Volume:12 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Jost Christian¹²^ORCID,Darowski Diana¹^ORCID,Challier John¹,Pulko Vesna¹,Hanisch Lydia J¹,Xu Wei¹^ORCID,Mössner Ekkehard¹,Bujotzek Alexander³,Klostermann Stefan³,Umana Pablo¹,Kontermann Roland E.⁴^ORCID,Klein Christian¹^ORCID

Affiliation:

1. Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland

2. Athebio AG, Zurich, Switzerland

3. Roche Innovation Center Munich, Roche Pharma Research & Early Development, Penzberg, Germany

4. University of Stuttgart, Stuttgart, Germany

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2020.1840709

Reference52 articles.

1. Redirected T Cell Cytotoxicity in Cancer Therapy

2. Bispecific antibodies: a mechanistic review of the pipeline

3. The making of bispecific antibodies

4. CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

5. A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The physiological interactome of TCR-like antibody therapeutics in human tissues;Nature Communications;2024-04-16

2. Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity;Trends in Biotechnology;2022-07